Latest news

New strategy for Parkinson's disease the treatment of based on conjugated inhibitory oligonucleotides

A study recently published in Therapy Molecular journal shows that the selective reduction of α-synuclein expression in monoaminergic neurons induced by inhibitory oligonucleotides increases dopaminergic and serotonergic function, both deficient in Parkinson's disease (PD).

Read More